Results by title

An ideal entry point into health economics for everyone from aspiring economists to healthcare professionals.

The economics of healthcare are messy. For most consumers, there’s little control over costs or services. Sometimes doctors are paid a lot; other times they aren’t paid at all. Insurance and drug companies are evil, except when they’re not. If economics is the study of market efficiency, how do we make sense of this?

Better Health Economics is a warts-and-all introduction to a field that is more exceptions than rules. Economists Tal Gross and Matthew J. Notowidigdo offer readers an accessible primer on the field’s essential concepts, a review of the latest research, and a framework for thinking about this increasingly imperfect market.

A love letter to a traditionally unlovable topic, Better Health Economics provides an ideal entry point for students in social science, business, public policy, and healthcare. It’s a reminder that healthcare may be a failed market—but it’s our failed market.

This is an auto-narrated audiobook version of this book.

An ideal entry point into health economics for everyone from aspiring economists to healthcare professionals.

The economics of healthcare are messy. For most consumers, there’s little control over costs or services. Sometimes doctors are paid a lot; other times they aren’t paid at all. Insurance and drug companies are evil, except when they’re not. If economics is the study of market efficiency, how do we make sense of this?

Better Health Economics is a warts-and-all introduction to a field that is more exceptions than rules. Economists Tal Gross and Matthew J. Notowidigdo offer readers an accessible primer on the field’s essential concepts, a review of the latest research, and a framework for thinking about this increasingly imperfect market.

A love letter to a traditionally unlovable topic, Better Health Economics provides an ideal entry point for students in social science, business, public policy, and healthcare. It’s a reminder that healthcare may be a failed market—but it’s our failed market.

This is an auto-narrated audiobook edition of this book.

There is little debate that health care in the United States is in need of reform. But where should those improvements begin? With insurers? Drug makers? The doctors themselves? In Big Med, David Dranove and Lawton Robert Burns argue that we’re overlooking the most ubiquitous cause of our costly and underperforming system: megaproviders, the expansive health care organizations that have become the face of American medicine. Your local hospital is likely part of one. Your doctors, too. And the megaproviders are bad news for your health and your wallet.

Drawing on decades of combined expertise in health care consolidation, Dranove and Burns trace Big Med’s emergence in the 1990s, followed by its swift rise amid false promises of scale economies and organizational collaboration. In the decades since, megaproviders have gobbled up market share and turned independent physicians into salaried employees of big bureaucracies, while delivering on none of their early promises. For patients this means higher costs and lesser care. Meanwhile, physicians report increasingly low morale, making it all but impossible for most systems to implement meaningful reforms.

In Big Med, Dranove and Burns combine their respective skills in economics and management to provide a nuanced explanation of how the provision of health care has been corrupted and submerged under consolidation. They offer practical recommendations for improving competition policies that would reform megaproviders to actually achieve the efficiencies and quality improvements they have long promised.
This is an essential read for understanding the current state of the health care system in America—and the steps urgently needed to create an environment of better care for all of us.

    First, Do No Harm shows how health care professionals, with the best intentions of providing excellent, holistic health care, can nonetheless perpetuate violence against vulnerable patients. The essays investigate the need to rethink contemporary healthcare practices in ways that can bring the art and science of medicine back into sorely needed balance.
    These ground-breaking studies by noted scholars question commonly held assumptions in contemporary healthcare that underlie oppressive power dynamics and even violence for patients and their families. The contributors discuss such topics as women and violence, life-support technologies, and healthcare professionals’ own experiences as patients. First, Do No Harm opens the discourse for reaching new understandings, from reassessing the meaning of "quality of life" to questioning the appropriateness of the very language used by healthcare professionals. It will be welcomed by healthcare workers and by scholars in nursing, medicine, and the allied health sciences.

A comparative analysis of both formal and informal long-term care in ten of the world’s wealthiest countries.

Nations throughout the world are in the midst of an enormous demographic transition, with life expectancy increasing and fertility falling, leading to a rapidly aging population and critical implications for long-term care around the world. This volume documents and compares long-term care programs in ten wealthy countries.

Analyses of survey data and government statistics show that the costs of long-term care are beyond the financial means of a large fraction of the elderly population in most countries, particularly the oldest and most disabled. As a result, public systems bear most of the cost of formal long-term care, such as care in an institution or paid home care. Most countries spend more on nursing homes than on home care, but this relationship varies widely as does the mix of care needs and resources used to define eligibility for public funding. At the same time, most care is provided informally through family or unpaid caregivers. The costs of informal care, including the foregone earnings of caregivers, are estimated to account for at least one-third of all long-term care spending in every country. Thus, any estimate of the social costs of long-term care must account for the implicit costs of informal care.

A first-of-its-kind text for students entering a career in kinesiology, Professionalism and Healthcare Ethics for Kinesiologists provides a thorough explanation of professionalism and ethical theories, a method and many examples for making ethical decisions in kinesiology workplaces, and an exploration into accountability, governance topics, and the scope of professional misconduct in kinesiology, as well as the possible future of professional kinesiology education and ethics.

Strategic Communications in Healthcare: Building Trust, Reputation and Impact is a landmark textbook that combines innovative approaches to communication with the enduring principles that drive effectiveness, influence, and results. Drawing on the real-world expertise of nationally recognized leaders Rose Glenn and David Jarrard—along with a who’s who of senior healthcare communicators and educators—this hands-on guide brings together trust-building, messaging, crisis response, culture, brand, patient experience, research, measurement, AI, and more foundational elements into a cohesive framework for students and professionals alike.

A timely investigation of the potential economic effects, both realized and unrealized, of artificial intelligence within the United States healthcare system.

In sweeping conversations about the impact of artificial intelligence on many sectors of the economy, healthcare has received relatively little attention. Yet it seems unlikely that an industry that represents nearly one-fifth of the economy could escape the efficiency and cost-driven disruptions of AI.

The Economics of Artificial Intelligence: Health Care Challenges brings together contributions from health economists, physicians, philosophers, and scholars in law, public health, and machine learning to identify the primary barriers to entry of AI in the healthcare sector. Across original papers and in wide-ranging responses, the contributors analyze barriers of four types: incentives, management, data availability, and regulation. They also suggest that AI has the potential to improve outcomes and lower costs. Understanding both the benefits of and barriers to AI adoption is essential for designing policies that will affect the evolution of the healthcare system.